Literature DB >> 890363

Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen.

N B Loudon, M Foxwell, D M Potts, A L Guild, R V Short.   

Abstract

The frequency of menstruation was reduced to once every three months in 196 women by the continuous administration of the oral contraceptive pill, Minilyn, for 84 days (tri-cycle regimen). No pregnancies occurred. One hundred and sixty-one women (82%) welcomed the reduction in the number of periods with the associated freedom from menstrual and premenstrual symptoms, and many found the tri-cycle regimen easier to follow. Weight gain of more than 2 kg, irregular cycle control, especially in the first three months, breast tenderness, and headaches were the main side effects. Menstrual loss was unchanged or reduced in all but seven women. The doctors and nurses on the clinic staff were less enthusiastic about this regimen than the volunteers themselves.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 890363      PMCID: PMC1630912          DOI: 10.1136/bmj.2.6085.487

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  1 in total

1.  Intramuscular depomedroxyprogesterone acetate for contraception.

Authors:  S Koetsawang; S Srisuphandit; S Srivanaboon; P Bhiraleus; D Rachawat; O Kiriwat; A Koetsawang
Journal:  J Med Assoc Thai       Date:  1974-08
  1 in total
  18 in total

1.  Epidemiology of endometriosis.

Authors:  J Guillebaud
Journal:  BMJ       Date:  1993-04-03

2.  Acceleration. II: short duration acceleration.

Authors:  F J Mills; R M Harding
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-21

3.  New prospects for luteinising hormone releasing hormone as a contraceptive and therapeutic agent.

Authors:  H M Fraser
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-09

4.  Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial.

Authors:  Romana Dmitrovic; Allen R Kunselman; Richard S Legro
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

Review 5.  A contemporary approach to dysmenorrhea in adolescents.

Authors:  Zeev Harel
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Extended cycles with the combined oral contraceptive chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg: pooled analysis of data from three large-scale, non-interventional, observational studies.

Authors:  Gunther Göretzlehner; Susanne Waldmann-Rex; Georg A K Schramm
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 7.  Long-cycle treatment with oral contraceptives.

Authors:  Inka Wiegratz; Herbert Kuhl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Characteristics of scheduled bleeding manipulation with combined hormonal contraception in university students.

Authors:  Hannah Lakehomer; Paul F Kaplan; David G Wozniak; Christopher T Minson
Journal:  Contraception       Date:  2013-01-08       Impact factor: 3.375

Review 9.  Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception.

Authors:  Alison Edelman; Elizabeth Micks; Maria F Gallo; Jeffrey T Jensen; David A Grimes
Journal:  Cochrane Database Syst Rev       Date:  2014-07-29

10.  Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives.

Authors:  Giuseppe Benagiano; Sabina Carrara; Valentina Filippi
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.